VIMIAN GROUP AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.05 SEK | +2.21% |
|
-3.69% | +1.52% |
| Mar. 28 | Nordic Shares Decreased Thursday; BioGaia Series B Posted Biggest Loss | DJ |
| Mar. 19 | Nordic Stocks Decreased Tuesday; Autostore Holdings Posted Biggest Loss | DJ |
Business Summary
Number of employees: 1,100
Sales per Business
| SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
Specialty Pharma
44.4
%
| 1,322 | 44.2 % | 1,691 | 44.4 % | +27.99% |
MedTech
34.2
%
| 1,079 | 36.1 % | 1,303 | 34.2 % | +20.74% |
Veterinary
14.9
%
| 357 | 11.9 % | 567 | 14.9 % | +58.65% |
Diagnostics
6.5
%
| 234 | 7.8 % | 246 | 6.5 % | +5.15% |
Sales per region
| SEK in Million | 2022 | Weight | 2023 | Weight | Delta |
|---|---|---|---|---|---|
United States
37.7
%
| 1,208 | 40.4 % | 1,435 | 37.7 % | +18.80% |
United Kingdom
11.4
%
| 329 | 11.0 % | 435 | 11.4 % | +32.00% |
Other Countries
9.3
%
| 494 | 16.5 % | 354 | 9.3 % | -28.36% |
Italy
7.2
%
| 234 | 7.8 % | 274 | 7.2 % | +16.93% |
France
5.8
%
| 196 | 6.5 % | 220 | 5.8 % | +12.59% |
Australia
5.7
%
| - | - | 215 | 5.7 % | - |
Sweden
5.6
%
| 107 | 3.6 % | 214 | 5.6 % | +100.13% |
Denmark
4.7
%
| 141 | 4.7 % | 178 | 4.7 % | +26.01% |
Germany
4.3
%
| 147 | 4.9 % | 165 | 4.3 % | +12.25% |
Canada
3.8
%
| - | - | 145 | 3.8 % | - |
Netherlands
2.4
%
| 69 | 2.3 % | 91 | 2.4 % | +30.97% |
New Zealand
2.2
%
| 67 | 2.3 % | 84 | 2.2 % | +23.84% |
Managers
| Managers | Title | Age | Since |
|---|---|---|---|
Patrik Eriksson
CEO | Chief Executive Officer | 56 | Dec. 31 |
| Director of Finance/CFO | 45 | 21-12-31 | |
| Investor Relations Contact | 43 | 21-08-31 | |
Carl-Johan Ehn
LAW | General Counsel | - | 22-08-14 |
Martin Bengtson
PRN | Corporate Officer/Principal | 43 | 20-12-31 |
Members of the board
| Members of the board | Title | Age | Since |
|---|---|---|---|
Mikael Dolsten
BRD | Director/Board Member | 65 | 20-12-31 |
Petra Rumpf
BRD | Director/Board Member | 57 | 21-12-31 |
| Director/Board Member | 54 | 22-12-31 | |
| Director/Board Member | 41 | 20-12-31 | |
Frida Westerberg
BRD | Director/Board Member | 49 | 20-12-31 |
| Chairman | 47 | 20-12-31 | |
Theodor Bonnier
BRD | Director/Board Member | 35 | 20-12-31 |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 0 | 12,878,208 | 0 | 0 | 40.37 % |
| Stock B | 1 | 509,542,790 | 210,909,673 ( 41.39 %) | 0 |
Company contact information
Group companies
| Name | Category and Sector |
|---|---|
Vimian FinCo AB
|
Sector
Sales per Business
Sales per region
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
2.566
EUR
Average target price
3.355
EUR
Spread / Average Target
+30.72%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +1.52% | 1.4B | |
| -19.09% | 72.39B | |
| -8.93% | 6.54B | |
| +21.38% | 3.43B | |
| -16.99% | 1.34B | |
| -3.81% | 1.26B | |
| -26.05% | 1.2B | |
| -12.71% | 1.12B | |
| -4.03% | 990M | |
| -23.05% | 805M |
- Stock Market
- Equities
- VIMIAN Stock
- Company Vimian Group AB
